These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11890253)
1. Homotypic cell-cell contacts stimulate the motile activity of rat prostate cancer cells. Madeja Z; Miekus K; Sroka J; Djamgoz MB; Korohoda W BJU Int; 2001 Nov; 88(7):776-86. PubMed ID: 11890253 [TBL] [Abstract][Full Text] [Related]
2. Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Miekus K; Czernik M; Sroka J; Czyz J; Madeja Z Biol Cell; 2005 Dec; 97(12):893-903. PubMed ID: 15907197 [TBL] [Abstract][Full Text] [Related]
3. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Mohler JL; Levy F; Sharief Y Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730 [TBL] [Abstract][Full Text] [Related]
5. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581 [TBL] [Abstract][Full Text] [Related]
7. Biometric assessment of prostate cancer's metastatic potential. Cooper CR; Emmett N; Harris-Hooker S; Patterson R; Cooke DB World J Urol; 1994; 12(6):304-7. PubMed ID: 7881466 [TBL] [Abstract][Full Text] [Related]
8. Statistical and fractal analyses of rat prostate cancer cell motility in a direct current electric field: comparison of strongly and weakly metastatic cells. Siwy Z; Mycielska ME; Djamgoz MB Eur Biophys J; 2003 Mar; 32(1):12-21. PubMed ID: 12632202 [TBL] [Abstract][Full Text] [Related]
9. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells. Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479 [TBL] [Abstract][Full Text] [Related]
10. Genistein inhibits the contact-stimulated migration of prostate cancer cells. Miękus K; Madeja Z Cell Mol Biol Lett; 2007 Sep; 12(3):348-61. PubMed ID: 17297558 [TBL] [Abstract][Full Text] [Related]
11. Patterning of endocytic vesicles and its control by voltage-gated Na+ channel activity in rat prostate cancer cells: fractal analyses. Krasowska M; Grzywna ZJ; Mycielska ME; Djamgoz MB Eur Biophys J; 2004 Oct; 33(6):535-42. PubMed ID: 15024523 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of dunning rat prostate tumor fluid on proliferation of the metastatic MAT-LyLu cell line. Bugan I; Altun S Asian Pac J Cancer Prev; 2015; 16(2):831-6. PubMed ID: 25684533 [TBL] [Abstract][Full Text] [Related]
13. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity. Mycielska ME; Fraser SP; Szatkowski M; Djamgoz MB J Cell Physiol; 2003 Jun; 195(3):461-9. PubMed ID: 12704656 [TBL] [Abstract][Full Text] [Related]
14. Dimethylsulfoxide-induced changes in a rat prostate adenocarcinoma. Wenger AS; Hall M; Mickey GH; Silverman L; Fried FA; Mickey DD Prostate; 1985; 6(4):329-41. PubMed ID: 4088948 [TBL] [Abstract][Full Text] [Related]
15. Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations. Czernik M; Sroka J; Madeja Z; Czyz J Cell Mol Biol Lett; 2008; 13(3):327-38. PubMed ID: 18292973 [TBL] [Abstract][Full Text] [Related]
16. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer. Abel PD; Foster CS; Tebbutt S; Williams G J Urol; 1990 Sep; 144(3):760-5. PubMed ID: 2388349 [TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline. Wenger AS; Mickey DD; Hall M; Silverman LM; Mickey GH; Fried FA J Urol; 1984 Jun; 131(6):1232-6. PubMed ID: 6539387 [TBL] [Abstract][Full Text] [Related]
18. Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Fraser SP; Ding Y; Liu A; Foster CS; Djamgoz MB Cell Tissue Res; 1999 Mar; 295(3):505-12. PubMed ID: 10022970 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416 [TBL] [Abstract][Full Text] [Related]
20. Effects of gadolinium ions upon rat prostatic cancer cell lines of markedly different metastatic potential. Verrall J; Fraser SP; Djamgoz MB Cancer Lett; 1999 Oct; 145(1-2):79-83. PubMed ID: 10530773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]